Showing results (1561-1570 of 1,899) with videos related to
Sort By:
Pageof 190
Immunotherapy|April 29, 2015
IL-11 signaling as a therapeutic target for cancerTracy L Putoczki, Matthias ErnstImmunotherapy|September 5, 2025
First-line pembrolizumab for metastatic NSCLC in lower-middle-income countries: bridging the efficacy-effectiveness gapUllas Batra, Mansi Sharma, Alexis Andrew Miller, et al.Immunotherapy|August 4, 2016
A pooled analysis of nivolumab for the treatment of advanced non-small-cell lung cancer and the role of PD-L1 as a predictive biomarkerPedro N Aguiar, Ilka Lopes Santoro, Hakaru Tadokoro, et al.Immunotherapy|August 4, 2016
A recombinant TGF-β1 vaccine ameliorates diabetic nephropathy in OLETF ratsHaojun Zhang, Hua Wang, Meihua Yan, et al.Immunotherapy|August 4, 2016
Current status of engineered T-cell therapy for synovial sarcomaMatthew Dallos, William D Tap, Sandra P D'AngeloImmunotherapy|August 4, 2016
Tau-based therapeutics for Alzheimer's disease: active and passive immunotherapyFrancesco Panza, Vincenzo Solfrizzi, Davide Seripa, et al.Immunotherapy|August 4, 2016
Strategies to control human cytomegalovirus infection in adult hematopoietic stem cell transplant recipientsDaniele Lilleri, Giuseppe GernaImmunotherapy|May 8, 2020
Non-coding RNA and immune-checkpoint inhibitors: friends or foes?Dmitrii Shek, Scott A Read, Liia Akhuba, et al.Immunotherapy|May 5, 2020
Notable response to nivolumab during the treatment of SMARCA4-deficient thoracic sarcoma: a case reportYuki Iijima, Rie Sakakibara, Masahiro Ishizuka, et al.Immunotherapy|June 13, 2015
CAR T-cell therapy: toxicity and the relevance of preclinical modelsMilena Kalaitsidou, Gray Kueberuwa, Antje Schütt, et al.Pageof 190